NCT02184364View on ClinicalTrials.gov

Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

September 30, 2000

Conditions
Menopause
Interventions
DRUG

Low dose of Klimadynon®

DRUG

Medium dose of Klimadynon®

DRUG

High dose of Klimadynon®

DRUG

Oestrofeminal®

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02184364 - Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints | Biotech Hunter | Biotech Hunter